(2) Methodological variations: The referenced studies employed the GSSG substrate method or a modification of Beutlers method, while our study utilized the ultraviolet enzymatic method
Azuma, S.W
#PharmaNews #PharmaResults #EarningsUpdate #IndianPharma #PharmaUpdates #Harshal #PharmawithHJ #HJ Gland Pharma FY25 Results: Strong Margins, 31 Product Launches Gland Pharma Limited FY25 Results: Margins Hold Strong, Strategy Gathers Steam Financial Highlights: - FY25 Revenue: 5,617 Cr (1% YoY) - EBITDA Margin: 1,269 Cr (5% YoY) | Margin 23% - PAT: 698 Cr (10% YoY) | Margin at 12% - Dividend: 18/share final dividend recommended Business Highlights: - 31 product launches in FY25, including new molecules like Latanoprost & Dexamethasone - 32 ANDA approvals, 24 filings U.S
Complaints of the patch not working as promised, causing irritation, or being impossible to get refunds for, start surfacing online
Processing and Utilization Durian Processing and utilization of the fruit In producing regions, durian undergoes pre-processing